Medclone Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Hyderabad, Telangana, India, established in 2024.
2024 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Medclone Pharmaceuticals Private Limited

Medclone Pharmaceuticals Private Limited, a active private limited company, was established on 03 October 2024 in Hyderabad, Telangana, India. it holds CIN: U46497TS2024PTC189899. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vemula Rajinikanth (Director), Suman Neelam (Director). Past directors included Srinivas Konakala. It is based at H.No.2-4-1049/104, Flat No. 104, First Floor, Sai Ram Avenue, Road No.2, New Samathapuri Colony, Nagole, Hyderabad, Telangana, 500035.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497TS2024PTC189899

  • Registration Number

    189899

  • Incorporation Date

    03 October 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 5 Months
Company report

Medclone Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Medclone Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medclone Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vemula Rajinikanth Director 03 Oct 2024 Current
Suman Neelam Director 03 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medclone Pharmaceuticals.

Enhance accessibility to Medclone Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medclone Pharmaceuticals revenue growth over time
Medclone Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medclone Pharmaceuticals?

Unlock access to Medclone Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medclone Pharmaceuticals?

Unlock and access historical data on people associated with Medclone Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medclone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medclone Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medclone Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Vemula Rajinikanth was appointed as a Director was appointed as a Director on 03 Oct 2024 & has been associated with this company since 1 year 5 months . was documented.

  • Director Appointment

    The activity Suman Neelam was appointed as a Director was appointed as a Director on 03 Oct 2024 & has been associated with this company since 1 year 5 months . was completed.

  • Company Incorporation

    The activity Medclone Pharmaceuticals Private Limited was registered on 03 Oct 2024 with Roc Hyderabad & aged 1 year 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medclone Pharmaceuticals Private Limited?

The CIN of Medclone Pharmaceuticals Private Limited is U46497TS2024PTC189899.

Where is Medclone Pharmaceuticals Private Limited headquartered?

Medclone Pharmaceuticals Private Limited is headquartered at H.No.2-4-1049/104, Flat No. 104, First Floor, Sai Ram Avenue, Road No.2, New Samathapuri Colony, Nagole, Hyderabad, Telangana, 500035.

When was Medclone Pharmaceuticals Private Limited incorporated?

Medclone Pharmaceuticals Private Limited was incorporated on 03 October 2024.

Who are the current directors of Medclone Pharmaceuticals Private Limited?

The current directors of Medclone Pharmaceuticals Private Limited are

Is Medclone Pharmaceuticals Private Limited a listed company?

Medclone Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Medclone Pharmaceuticals Private Limited?

The authorized capital of Medclone Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available